Abdel Galil SM, Ezzeldin N, El-Boshy ME (2015) The role of serum IL-17 and IL-6 as biomarkers of disease activity and predictors of remission in patients with lupus nephritis. Cytokine 76(2):280–7. https://doi.org/10.1016/j.cyto.2015.05.007

AbouYabis AN, Bell GT (2021) Hemolytic Anemia Complicating COVID-19 Infection. J Hematol 10(5): 221–227. https://doi.org/10.14740/jh906

Ahn D-G, Shin H-J, Kim M-H, Lee S, Kim H-S, Myoung J et al (2020) Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19). J Microbiol Biotechnol 30(3):313–324. https://doi.org/10.4014/jmb.2003.03011

CAS  PubMed  Article  Google Scholar 

Ahsan N, Shah KV (2006) Polyomaviruses and human diseases. Adv Exp Med Biol 577:1–18. https://doi.org/10.1007/0-387-32957-9_1

CAS  PubMed  Article  Google Scholar 

Alberti P, Beretta S, Piatti M, Karantzoulis A, Piatti ML, Santoro P et al (2020) Guillain-Barré syndrome related to COVID-19 infection. Neurol Neuroimmunol Neuroinflamm 7(4):e741. https://doi.org/10.1212/NXI.0000000000000741

PubMed  PubMed Central  Article  Google Scholar 

Alegretti AP, Schneider L, Piccoli AK, Monticielo OA, Lora PS, Brenol JCT et al (2012) Diminished expression of complement regulatory proteins on peripheral blood cells from systemic lupus erythematosus patients. Clin Dev Immunol 2012:725684. https://doi.org/10.1155/2012/725684

PubMed  PubMed Central  Article  CAS  Google Scholar 

Amand M, Iserentant G, Poli A, Sleiman M, Fievez V, Sanchez IP et al (2017) Human CD56(dim)CD16(dim) cells as an individualized natural killer cell subset. Front Immunol 8:699. https://doi.org/10.3389/fimmu.2017.00699

PubMed  PubMed Central  Article  CAS  Google Scholar 

Amin NM (2008) Antiphospholipid syndromes in infectious diseases. Hematol Oncol Clin North Am 22(1):131–143. https://doi.org/10.1016/j.hoc.2007.10.001

PubMed  Article  Google Scholar 

Arnaud S, Budowski C, Tin SNW, Degos B (2020) Post SARS-CoV-2 Guillain-Barré syndrome. Clin Neurophysiol 131(7):1652–1654. https://doi.org/10.1016/j.clinph.2020.05.003

PubMed  PubMed Central  Article  Google Scholar 

Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann H-H, Zhang Y et al (2020) Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science 370(6515):eabd4585. https://doi.org/10.1126/science.abd4585

Article  PubMed  PubMed Central  Google Scholar 

Bastard P, Gervais A, Le Voyer T, Rosain J, Philippot Q, Manry J et al (2021) Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths. Sci Immunol 6(62):eabl4340. https://doi.org/10.1126/sciimmunol.abl4340

PubMed  PubMed Central  Article  Google Scholar 

Bengtsson AA, Sturfelt G, Truedsson L, Blomberg J, Alm G, Vallin H et al (2000) Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus 9(9):664–671. https://doi.org/10.1191/096120300674499064

CAS  PubMed  Article  Google Scholar 

Bijl M, Horst G, Limburg PC, Kallenberg CG (2001) Fas expression on peripheral blood lymphocytes in systemic lupus erythematosus (SLE): relation to lymphocyte activation and disease activity. Lupus 10(12):866–872. https://doi.org/10.1191/096120301701548517

CAS  PubMed  Article  Google Scholar 

Blanco-Melo D, Nilsson-Payant BE, Liu W-C, Uhl S, Hoagland D, Møller R, et al (2020) Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181(5):1036–1045.e9. https://doi.org/10.1016/j.cell.2020.04.026

Bogoch II, Watts A, Thomas-Bachli A, Huber C, Kraemer MUG, Khan K (2020) Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel. J Travel Med 27(2):taaa008. https://doi.org/10.1093/jtm/taaa008

Article  PubMed  PubMed Central  Google Scholar 

Borghi MO, Beltagy A, Garrafa E, Curreli D, Cecchini G, Bodio C et al (2020) Anti-phospholipid antibodies in COVID-19 are different from those detectable in the anti-phospholipid syndrome. Front Immunol 11: 584241. https://doi.org/10.3389/fimmu.2020.584241

Bourgonje AR, Abdulle AE, Timens W, Hillebrands J-L, Navis GJ, Gordijn SJ et al (2020) Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). J Pathol 251(3):228–248. https://doi.org/10.1002/path.5471

CAS  Article  PubMed  PubMed Central  Google Scholar 

Bowles L, Platton S, Yartey N, Dave M, Lee K, Hart DP et al (2020) Lupus anticoagulant and abnormal coagulation tests in patients with Covid-19. N Engl J Med 383(3):288–290. https://doi.org/10.1056/NEJMc2013656

PubMed  Article  Google Scholar 

Brito CA, Paiva JG, Pimentel FN, Guimarães RS, Moreira MR (2021) COVID-19 in patients with rheumatological diseases treated with anti-TNF. Ann Rheum Dis 80(5):e62 LP-e62. https://doi.org/10.1136/annrheumdis-2020-218171

Bronson PG, Chaivorapol C, Ortmann W, Behrens TW, Graham RR (2012) The genetics of type I interferon in systemic lupus erythematosus. Curr Opin Immunol 24(5):530–537. https://doi.org/10.1016/j.coi.2012.07.008

CAS  PubMed  Article  Google Scholar 

Caamaño DSJ, Beato RA (2020) Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2. J Clin Neurosci 77:230–232. https://doi.org/10.1016/j.jocn.2020.05.016

Article  CAS  Google Scholar 

Cantini F, Niccoli L, Matarrese D, Nicastri E, Stobbione P, Goletti D (2020) Baricitinib therapy in COVID-19: a pilot study on safety and clinical impact. J Infect 81(2):318–356. https://doi.org/10.1016/j.jinf.2020.04.017

CAS  PubMed  PubMed Central  Article  Google Scholar 

Casadevall A, Joyner MJ, Pirofski L-A (2020) SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy. J Clin Invest 130(10):5112–5114. https://doi.org/10.1172/JCI139760

CAS  PubMed  PubMed Central  Article  Google Scholar 

Cervia C, Nilsson J, Zurbuchen Y, Valaperti A, Schreiner J, Wolfensberger A et al (2021) Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19. J Allergy Clin Immunol 147(2):545-557.e9. https://doi.org/10.1016/j.jaci.2020.10.040

CAS  PubMed  Article  Google Scholar 

Channappanavar R, Fehr AR, Vijay R, Mack M, Zhao J, Meyerholz DK et al (2016) Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice. Cell Host Microbe 19(2):181–193. https://doi.org/10.1016/j.chom.2016.01.007

CAS  PubMed  PubMed Central  Article  Google Scholar 

Chen L, Liu HG, Liu W, Liu J, Liu K, Shang J et al (2020a) Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia. Zhonghua Jiehe He Huxi Zazhi Chin J Tuberc Respir Dis 43:E005. https://doi.org/10.3760/cma.j.issn.1001-0939.2020.0005

Google Scholar 

Chen Z, Hu J, Zhang Z, Jiang S, Han S, Yan D, et al (2020b) Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial. medRxiv. https://doi.org/10.1101/2020.03.22.20040758

Chowdhury MA, Hossain N, Kashem MA, Shahid MA, Alam A (2020) Immune response in COVID-19: a review. J Infect Public Health 13(11):1619–29. https://doi.org/10.1016/j.jiph.2020.07.001

Clark DN, Markham JL, Sloan CS, Poole BD (2013) Cytokine inhibition as a strategy for treating systemic lupus erythematosus. Clin Immunol 148(3):335–343. https://doi.org/10.1016/j.clim.2012.11.001

CAS  PubMed  Article  Google Scholar 

Coen M, Jeanson G, Almeida LAC, Hübers A, Stierlin F, Najjar I et al (2020) Guillain-Barré syndrome as a complication of SARS-CoV-2 infection. Brain Behav Immun 87:111-112. https://doi.org/10.1016/j.bbi.2020.04.074

CAS  PubMed  PubMed Central  Article  Google Scholar 

Cohn LA (1991) The influence of corticosteroids on host defense mechanisms. J Vet Intern Med 5(2):95–104. https://doi.org/10.1111/j.1939-1676.1991.tb00939.x

CAS  Article  PubMed  Google Scholar 

Cooper MA, Fehniger TA, Caligiuri MA (2001) The biology of human natural killer-cell subsets. Trends Immunol 22(11):633–640. https://doi.org/10.1016/s1471-4906(01)02060-9

CAS  PubMed  Article  Google Scholar 

Crinier A, Milpied P, Escalière B, Piperoglou C, Galluso J, Balsamo A et al (2018) High-dimensional single-cell analysis identifies organ-specific signatures and conserved NK cell subsets in humans and mice. Immunity 49(5):971-986.e5. https://doi.org/10.1016/j.immuni.2018.09.009

CAS  PubMed  PubMed Central  Article  Google Scholar 

Cucinotta D, Vanelli M (2020) WHO Declares COVID-19 a pandemic. Acta Biomed 91(1):157–160. https://doi.org/10.23750/abm.v91i1.9397

PubMed  PubMed Central  Google Scholar 

De Biasi S, Meschiari M, Gibellini L, Bellinazzi C, Borella R, Fidanza L et al (2020) Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat Commun 11(1):3434. https://doi.org/10.1038/s41467-020-17292-4

PubMed  PubMed Central  Article  CAS  Google Scholar 

Del Valle DM, Kim-Schulze S, Huang H-H, Beckmann ND, Nirenberg S, Wang B et al (2020) An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med 26(10):1636–1643. https://doi.org/10.1038/s41591-020-1051-9

PubMed  PubMed Central  Article  CAS  Google Scholar 

Diamond B (2020) The renin–angiotensin system: an integrated view of lung disease and coagulopathy in COVID-19 and therapeutic implications. J Exp Med 217(8):e20201000. https://doi.org/10.1084/jem.20201000

CAS  Article  PubMed  PubMed Central  Google Scholar 

Diamond MS, Kanneganti T-D (2022) Innate immunity: the first line of defense against SARS-CoV-2. Nat Immunol 23(2):165–176. https://doi.org/10.1038/s41590-021-01091-0

CAS  Article  PubMed  Google Scholar 

Diao B, Wang C, Tan Y, Chen X, Liu YY, Ning L et al (2020) Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol 11:827. https://doi.org/10.3389/fimmu.2020.00827

Article  PubMed  PubMed Central  Google Scholar 

Dinkin M, Gao V, Kahan J, Bobker S, Simonetto M, Wechsler P et al (2020) COVID-19 presenting with ophthalmoparesis from cranial nerve palsy. Neurology 95(5):221–223. https://doi.org/10.1212/WNL.0000000000009700

CAS  PubMed  Article  Google Scholar 

Domingo P, Mur I, Pomar V, Corominas H, Casademont J, de Benito N (2020) The four horsemen of a viral apocalypse: the pathogenesis of SARS-CoV-2 infection (COVID-19). EBioMedicine 58:102887. https://doi.org/10.1016/j.ebiom.2020.102887

PubMed  PubMed Central  Article